Skip to main content
John Young

John Young

John brings extensive healthcare, commercial and international experience to the Haleon Board following an extensive career at Pfizer over 34 years where he latterly served as Special Advisor to the CEO of Pfizer.

Prior to this role, John served on Pfizer’s Executive Leadership Team for ten years latterly as Chief Business Officer where he played an important role in cultivating the collaborations that led to the successful development and delivery of the Pfizer-BioNTech COVID-19 vaccine.

John has led many large-scale transformations, including the formation of the joint venture with GSK to create a premier global consumer healthcare business in 2019.

In addition to Haleon, John currently serves on the Boards of Johnson Controls International (JCI), Imbria Pharmaceuticals and Arvinas, Inc. John has also previously served on the Boards of European Federation of Pharmaceutical Industries Associations, The Biotechnology Innovation Organization, and the National Committee on United States-China Relations.

Favourite Haleon brand: Advil – I like keeping fit, and Advil helps me manage the aches and pains that result!